Thermo Fisher Scientific Bioproduction Articles

1. Beyond Protein A: Efficient Purification Strategies For Misbehaving mAbs 9/1/2026

   Next-generation antibody formats require more precise purification strategies. Explore how subdomain-specific VHH ligands can address structural heterogeneity, improve purity, and preserve stability.

2. Single-Use Clarification Across Process Scales 9/1/2026

   Gain insight into how combining centrifugation with targeted depth and chromatographic clarification can reduce filter demand, ease facility constraints, and support efficient mAb harvest.

3. Enhancing mAb Production: Advanced Downstream Purification Strategies 9/1/2026

   Explore how process optimization can address downstream mAb manufacturing bottlenecks, reduce labor and consumable costs, and support more efficient production without compromising performance.

4. Optimizing mAb Production: Upstream Process Intensification Strategies 9/1/2026

   See how integrated upstream and downstream intensification strategies can increase monoclonal antibody yield, streamline workflows, improve facility utilization, and reduce manufacturing costs.

5. Sterile Filter Membrane Selection For Cell Culture Media Filtration 8/24/2026

   Membrane design and filtration capacity affect pressure, throughput, and scale-up. See how comparative testing reveals opportunities to reduce required filtration area, capsule use, and changeouts.

6. Determining The True Cost Of Single-Use Fluid Management 8/24/2026

   Looking beyond unit price reveals how reliability, leak prevention, and shelf life affect bioprocessing costs. Make purchasing decisions that support resilient and predictable operations.

7. Improving AAV Manufacturing: Advancements In Full Capsid Enrichment 8/19/2026

   As AAV manufacturing matures, integrated optimization of capture, buffer chemistry, load conditioning, and AEX polishing enables scalable full capsid enrichment, improving product quality and manufacturability.

8. Engineering The Future Of Antibody-Drug Conjugates 6/26/2026

   As ADCs expand into broader use, upstream process design is becoming a competitive advantage. Discover how smarter media strategies and data-driven decision-making are helping teams reduce risk.

9. Exploring The Future Of Cell Expansion In Cell Therapy Manufacturing 6/26/2026

   As cell therapy scales, success depends on more than clinical promise. Smarter expansion strategies, automation, and flexible manufacturing platforms are becoming critical for improving consistency.

10. Delivering Critical Therapies With Speed And Safety 6/26/2026

    Faster approvals depend on treating regulation as part of development, not the finish line. See how early quality planning and strong agency communication can move therapies toward patients sooner.